Key result
Inter-hospital transfer of patients with STEMI was not significantly associated with a difference in in-hospital major adverse cardiovascular events compared to direct admission (HR 0.87, 95% CI 0.75-1.01).
Why the study?
Little was known about the current scenario of inter-hospital transfer for patients with acute myocardial infarction in China.
Does inter-hospital transfer affect treatment delays and in-hospital outcomes compared to direct admission in patients with acute myocardial infarction?
Cohort (n=94,623)
Yes
Does inter-hospital transfer affect treatment delays and in-hospital outcomes compared to direct admission in patients with acute myocardial infarction?
Hazard Ratio: 0.87 (95% CI 0.75–1.01)
Absolute Event Rate: 2.3% vs 3.3%
p-value: p=0.060
Inter-hospital transfer for AMI in China is common and associated with significant treatment delays and lower reperfusion rates compared to direct admission, highlighting the need to enhance regional revascularization networks.
No takes yet. Share an insight, caveat, or question.
Highlights systemic inefficiencies in STEMI transfer networks without showing short-term harm; leaves open whether these delays.
Hu et al. (2022) conducted a cohort in Acute myocardial infarction (AMI) (n=94,623). Inter-hospital transfer from a non-PCI hospital vs. Direct admission to a PCI-capable hospital was evaluated on In-hospital major adverse cardiovascular events (MACE) in patients with STEMI (HR 0.87, 95% CI 0.75-1.01, p=0.060). Inter-hospital transfer of patients with STEMI was not significantly associated with a difference in in-hospital major adverse cardiovascular events compared to direct admission (HR 0.87, 95% CI 0.75-1.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: